doi: 10.1016/0014-2999(90)90606-7.
Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin
Affiliations
- PMID: 2142092
- DOI: 10.1016/0014-2999(90)90606-7
Item in Clipboard
Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin
Eur J Pharmacol.
.
Abstract
Administration of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT; 0.25 mg/kg i.v.), to conscious rats increased plasma adrenaline and glucose levels for 30 and 60 min, respectively. Both 8-OH-DPAT-induced changes in plasma adrenaline and glucose levels were totally abolished in pentobarbital-anaesthetized rats. The present data indicate that pentobarbital anaesthesia, a procedure that is commonly used in pharmacological studies, prevents the release of adrenaline evoked by 5-HT1A receptor activation.
Similar articles
-
Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.Naunyn Schmiedebergs Arch Pharmacol. 1990 Apr;341(4):381-4. doi: 10.1007/BF00180665. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 1970616
-
Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats.Life Sci. 1991;48(26):2543-52. doi: 10.1016/0024-3205(91)90610-n. Life Sci. 1991. PMID: 1828521
-
Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.J Pharm Pharmacol. 1989 Apr;41(4):270-2. doi: 10.1111/j.2042-7158.1989.tb06450.x. J Pharm Pharmacol. 1989. PMID: 2568470
-
Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT.Eur J Pharmacol. 1990 Aug 21;185(1):11-8. doi: 10.1016/0014-2999(90)90205-k. Eur J Pharmacol. 1990. PMID: 2171956
-
Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).Eur J Pharmacol. 1988 Feb 16;147(1):111-8. doi: 10.1016/0014-2999(88)90639-5. Eur J Pharmacol. 1988. PMID: 2967189
Cited by
-
Effects of the 5-HT1 receptor agonists DP-5-CT, CGS 12066B, and RU 24969 on plasma adrenaline and glucose levels in the rat.Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):378-81. doi: 10.1007/BF00169452. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2255331
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
